EPOETIN相关论文
Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medica
Treatment for anemia has come a long way in the last 20 years since the first recombinant human erythropoietins were lic......
Optimal Treatment of Renal Anaemia (OPTA): improving the efficacy and efficiency of renal anaemia th
The medical care of renal anaemia has received much attention over the past decade, as nephrologists have recognized the......
Anemia Management and Association of Race With Mortality and Hospitalization in a Large Not-for-Prof
Background: The optimal hemoglobin target and possible toxicity of epoetin therapy in hemodialysis patients are controve......
Aim: This observational clinical study tested the effect of injection frequency of the biosimilar epoetin zeta on the we......
Hemoglobin Level Stability after a Switch from Darbepoetin Alfa to Epoetin Beta Pegol for the Treatm
Background: New erythropoiesis-stimulating agents (ESAs) with a longer half-life have been developed for the treatment o......
2008年9月26日，FDA的一项试验研究表明重组人红细胞生成素-α Epoetin alfa）治疗急性缺血性脑卒中·可导致与安慰剂相比更高的死......
促红细胞生成素（Epoetin）问世以前的年代，慢性肾脏病（CKD），尤其行血液透析患者常要定期输血来纠正贫血，因此有可能导致铁超负荷。白促红细......
据“新华美通”消息，欧洲血液协会（EHA）第11届大会于2006年6月首次公布的一项研究结果显示，采用一种新的人体细胞株内基因活化技术开发......
<正> 异名 Eprex 药效分类唾液糖蛋白激素开发单位 (瑞士)Cilag(Johnson & Johns0n) 上市厂商 (瑞士)Cilag(Johnson & Johnson)198......
